Ziopharm Oncology Company Profile (NASDAQ:ZIOP)

About Ziopharm Oncology

Ziopharm Oncology logoZIOPHARM Oncology, Inc. is a biopharmaceutical company. The Company is seeking to acquire, develop and commercialize, on its own or with partners, a portfolio of cancer therapies through synthetic immuno-oncology. Its clinical-stage product candidate, Ad-RTS-IL-12, is used with the oral activator veledimex. The Company's Ad-RTS-IL-12 + veledimex has been evaluated in two Phase II studies, the first for the treatment of metastatic melanoma, and the second for the treatment of unresectable recurrent or metastatic breast cancer. It has initiated the Phase I study for malignant glioma. The Company has completed the Phase II monotherapy studies in melanoma and breast cancer using Ad-RTS-IL-12 + veledimex. It has initiated a Phase Ib/II study of Ad-RTS-hIL-12 + veledimex following chemotherapy for the treatment of patients with locally metastatic breast cancer. Its initial drug candidate being developed using the synthetic immuno-oncology platform is Ad-RTS-IL-12 + veledimex.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ZIOP
  • CUSIP: 98973P10
Key Metrics:
  • Previous Close: $5.48
  • 50 Day Moving Average: $5.47
  • 200 Day Moving Average: $6.43
  • 52-Week Range: $4.45 - $14.93
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -12.40
  • P/E Growth: 0.00
  • Market Cap: $771.23M
  • Outstanding Shares: 130,496,000
  • Beta: 1.63
Profitability:
  • Net Margins: -2,292.26%
  • Return on Equity: -100.01%
  • Return on Assets: -34.70%
Debt:
  • Current Ratio: 7.90%
  • Quick Ratio: 7.90%
Additional Links:
Companies Related to Ziopharm Oncology:

Analyst Ratings

Consensus Ratings for Ziopharm Oncology (NASDAQ:ZIOP) (?)
Ratings Breakdown: 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $10.83 (94.15% upside)

Analysts' Ratings History for Ziopharm Oncology (NASDAQ:ZIOP)
Show:
DateFirmActionRatingPrice TargetDetails
8/15/2016Griffin SecuritiesReiterated RatingBuy$21.00View Rating Details
8/10/2016Wells Fargo & Co.UpgradeUnderperform -> Market PerformView Rating Details
7/18/2016MizuhoReiterated RatingNeutral$7.00 -> $5.00View Rating Details
6/2/2016Raymond James Financial Inc.Initiated CoverageMarket PerformView Rating Details
1/15/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details
6/22/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$15.00 -> $10.00View Rating Details
5/13/2015GuggenheimInitiated CoverageNeutralView Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Ziopharm Oncology (NASDAQ:ZIOP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2016        
8/9/2016Q216($0.11)($1.01)$1.52 million$1.70 millionViewN/AView Earnings Details
5/10/2016Q1($0.08)($0.09)$1.89 million$1.97 millionViewN/AView Earnings Details
2/24/2016Q4($0.07)($0.07)ViewN/AView Earnings Details
11/2/2015Q315($0.13)($0.14)$1.19 million$1.90 millionViewN/AView Earnings Details
8/10/2015Q2($0.22)($0.11)ViewN/AView Earnings Details
5/7/2015($0.13)($0.10)$0.20 million$0.30 millionViewN/AView Earnings Details
2/26/2015Q414($0.14)($0.09)$420.00 million$0.34 millionViewN/AView Earnings Details
10/30/2014Q314($0.12)($0.06)$3.43 millionViewN/AView Earnings Details
8/7/2014Q214($0.17)($0.06)$7.50 million$0.20 millionViewN/AView Earnings Details
5/8/2014Q114($0.10)($0.10)$0.20 million$0.20 millionViewN/AView Earnings Details
3/3/2014Q413($0.15)($0.09)$0.20 million$0.20 millionViewN/AView Earnings Details
10/22/2013Q313($0.17)($0.20)$0.20 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.24)($0.22)$0.20 million$0.20 millionViewN/AView Earnings Details
3/18/2013Q4 2012($0.29)($0.48)$0.17 million$0.20 millionViewN/AView Earnings Details
11/8/2012Q312($0.28)($0.28)$0.20 million$0.20 millionViewN/AView Earnings Details
8/2/2012($0.23)($0.29)ViewN/AView Earnings Details
5/3/2012($0.22)($0.25)ViewN/AView Earnings Details
2/29/2012($0.23)($0.24)ViewN/AView Earnings Details
11/3/2011($0.28)($0.01)ViewN/AView Earnings Details
8/1/2011($0.23)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Ziopharm Oncology (NASDAQ:ZIOP)
Current Year EPS Consensus Estimate: $-1.34 EPS
Next Year EPS Consensus Estimate: $-0.45 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.07)($0.07)($0.07)
Q2 20161($0.12)($0.12)($0.12)
Q3 20161($0.12)($0.12)($0.12)
Q4 20161($0.11)($0.11)($0.11)
Q2 20171($0.12)($0.12)($0.12)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Ziopharm Oncology (NASDAQ:ZIOP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Ziopharm Oncology (NASDAQ:ZIOP)
Insider Ownership Percentage: 11.50%
Institutional Ownership Percentage: 44.95%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/4/2015Murray BrennanDirectorSell40,000$9.70$388,000.00View SEC Filing  
2/9/2015Randal J KirkDirectorBuy1,440,000$8.75$12,600,000.00View SEC Filing  
10/29/2013Randal J KirkDirectorBuy2,857,143$3.50$10,000,000.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Ziopharm Oncology (NASDAQ:ZIOP)
DateHeadline
News Icon2 Stocks Attracting Analyst Attention: KapStone Paper and ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - September 28 at 5:17 AM
News IconActive Biotech Stock News: Alexion Pharmaceuticals, Inc. (ALXN), ZIOPHARM Oncology, Inc. (ZIOP) - The Independent Republic (NASDAQ:ZIOP)
theindependentrepublic.com - September 28 at 5:17 AM
News Icon2 Biotech Stocks News And Price Trends: ZIOPHARM Oncology, Inc. (UTC:ZIOP), Eleven Biotherapeutics, Inc ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - September 28 at 5:17 AM
capitalcube.com logoETF’s with exposure to ZIOPHARM Oncology, Inc. : September 27, 2016 (NASDAQ:ZIOP)
www.capitalcube.com - September 27 at 8:08 PM
News IconFirst Week of November 18th Options Trading For ZIOPHARM Oncology (ZIOP) (NASDAQ:ZIOP)
www.stockoptionschannel.com - September 21 at 7:45 PM
News IconBiotech Stocks Worth a Closer Look: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Celgene Corporation (NASDAQ:CELG) - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - September 21 at 12:03 PM
News IconBiotech stocks for your portfolio: Celldex Therapeutics, Inc. (CLDX), ZIOPHARM Oncology, Inc. (ZIOP) - The Independent Republic (NASDAQ:ZIOP)
theindependentrepublic.com - September 20 at 8:34 AM
News IconTop Biotechnology Stock Picking: Celldex Therapeutics, Inc. (CLDX), ZIOPHARM Oncology, Inc. (ZIOP) - The Independent Republic (NASDAQ:ZIOP)
theindependentrepublic.com - September 19 at 3:41 PM
News IconHC Stocks Impression! Aetna Inc (AET), ZIOPHARM Oncology Inc ... - share market updates (press release) (NASDAQ:ZIOP)
sharemarketupdates.com - September 19 at 3:41 PM
News IconZIOPHARM Oncology Inc (NASDAQ:ZIOP) - Cosumnes Connection (subscription) (NASDAQ:ZIOP)
www.crcconnection.com - September 17 at 5:16 AM
News IconQuarterly Financial Review of ZIOPHARM Oncology Inc (NASDAQ ... - Newburg Press (NASDAQ:ZIOP)
newburghpress.com - September 17 at 5:16 AM
News IconAnalysts Valuations For Two Stocks: Investors Real Estate Trust (NYSE:IRET), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - September 14 at 8:29 PM
thestreet.com logoZIOP January 2019 Options Begin Trading - TheStreet.com (NASDAQ:ZIOP)
www.thestreet.com - September 13 at 5:13 AM
News IconHC Stocks News Ring= Intrexon Corp (XON), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - share market updates (press release) (NASDAQ:ZIOP)
sharemarketupdates.com - September 13 at 5:13 AM
capitalcube.com logoZIOPHARM Oncology, Inc. – Value Analysis (NASDAQ:ZIOP) : September 12, 2016 (NASDAQ:ZIOP)
www.capitalcube.com - September 12 at 7:42 PM
News IconNew Broker Ratings For ZIOPHARM Oncology Inc (ZIOP) - Cosumnes Connection (subscription) (NASDAQ:ZIOP)
www.crcconnection.com - September 9 at 7:50 PM
News IconHot Biotech Stocks Recap: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Halozyme Therapeutics, Inc. (NASDAQ:HALO) - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - September 9 at 7:50 PM
capitalcube.com logoZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bullish Manner : ZIOP-US : September 9, 2016 (NASDAQ:ZIOP)
www.capitalcube.com - September 9 at 7:50 PM
finance.yahoo.com logoZiopharm put sale bets on end to slide (NASDAQ:ZIOP)
finance.yahoo.com - September 9 at 7:50 PM
News IconTime To Put On The Watch List? - ZIOPHARM (ZIOP), CEL-SCI (CVM) - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - September 9 at 5:25 AM
News IconPlacing ZIOPHARM Oncology Inc (NASDAQ:ZIOP) Shares Under the Microscope - National Daily Press (NASDAQ:ZIOP)
www.nationaldailypress.com - September 9 at 5:25 AM
News IconStock Struggling for the Quarter: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) - Post News (NASDAQ:ZIOP)
www.kentuckypostnews.com - September 4 at 5:24 AM
News IconHC Stocks Newsbeat - Skyline Medical Inc (NASDAQ:SKLN ... - share market updates (press release) (NASDAQ:ZIOP)
sharemarketupdates.com - September 2 at 6:27 AM
News IconTrading the Biotech News: Celgene Corporation (NASDAQ:CELG), ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - September 2 at 6:27 AM
News IconTime To Put On The Watch List? – ZIOPHARM Oncology, Inc ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - September 2 at 6:27 AM
finance.yahoo.com logoZIOPHARM to Present at the 2016 Wells Fargo Healthcare Conference (NASDAQ:ZIOP)
finance.yahoo.com - September 1 at 11:38 AM
News IconNotable Stock's Buzzers: ZIOPHARM Oncology Inc.(NASDAQ:ZIOP ... - NYSE Journal (press release) (NASDAQ:ZIOP)
stockznews.com - August 27 at 5:22 AM
benzinga.com logoMid-Afternoon Market Update: Guess? Jumps On Earnings Beat; Signet Jewelers Shares Tumble - Benzinga (NASDAQ:ZIOP)
www.benzinga.com - August 25 at 8:39 PM
News IconBiotech Stocks To Put On Your Watch List: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), ImmunoCellular Therapeutics ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 25 at 5:22 AM
News IconAnalyst's keeping an Eye on: ZIOPHARM Oncology Inc (NASDAQ ... - Newburg Press (NASDAQ:ZIOP)
newburghpress.com - August 23 at 8:32 PM
News IconZIOPHARM Oncology, Inc.'s (ZIOP): Investor's Alert - Hot Stocks Point (NASDAQ:ZIOP)
www.hotstockspoint.com - August 23 at 8:32 PM
News IconIntraday Active Biotech Stocks News: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Vertex Pharmaceuticals Incorporated ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 23 at 8:32 PM
thestreet.com logoZIOP April 2017 Options Begin Trading (NASDAQ:ZIOP)
www.thestreet.com - August 22 at 8:22 PM
finance.yahoo.com logoZIOPHARM ONCOLOGY INC Financials (NASDAQ:ZIOP)
finance.yahoo.com - August 18 at 8:37 PM
investornewswire.com logoCan ZIOPHARM Oncology Inc (NASDAQ:ZIOP) Keep Up With Analyst Expectations? - Investor Newswire (NASDAQ:ZIOP)
www.investornewswire.com - August 18 at 11:36 AM
marketnewsvideo.com logoNotable Wednesday Option Activity: FDX, ZIOP, BAH (NASDAQ:ZIOP)
www.marketnewsvideo.com - August 17 at 8:44 PM
News IconZIOPHARM Oncology Inc. (NASDAQ:ZIOP): It’s All About Timing The Buy Action To Make Quick Money (NASDAQ:ZIOP)
www.marketnewscall.com - August 17 at 11:24 AM
News IconAnalysts Valuations For Two Stocks: ZIOPHARM Oncology Inc. (ZIOP), Bed Bath & Beyond Inc. (BBBY) - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 16 at 11:47 AM
capitalcube.com logoZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bullish Manner : ZIOP-US : August 16, 2016 (NASDAQ:ZIOP)
www.capitalcube.com - August 16 at 11:47 AM
News IconZIOPHARM Oncology Inc. (NASDAQ:ZIOP): That’s How We Bought At $5.09 And Now Up 15% Already (NASDAQ:ZIOP)
www.marketnewscall.com - August 15 at 8:44 PM
capitalcube.com logoETF’s with exposure to ZIOPHARM Oncology, Inc. : August 15, 2016 (NASDAQ:ZIOP)
www.capitalcube.com - August 15 at 8:44 PM
News IconBiotech news that matter for investors: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Sangamo Biosciences Inc ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 12 at 8:35 PM
capitalcube.com logoZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:ZIOP)
www.capitalcube.com - August 12 at 8:35 PM
News IconBiotech news that matter for investors: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), ImmunoCellular Therapeutics, Ltd ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 11 at 9:04 PM
finance.yahoo.com logoZIOPHARM upgraded by Wells Fargo (NASDAQ:ZIOP)
finance.yahoo.com - August 10 at 9:11 PM
thestreet.com logoZiopharm Oncology (ZIOP) Stock Advances After Q2 Results, Upgrade (NASDAQ:ZIOP)
www.thestreet.com - August 10 at 9:11 PM
globenewswire.com logoZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities (NASDAQ:ZIOP)
globenewswire.com - August 9 at 8:46 PM
reuters.com logoBRIEF-Ziopharm Q2 loss per share $1.01 (NASDAQ:ZIOP)
www.reuters.com - August 9 at 8:45 PM
twst.com logoZIOPHARM Oncology Inc.: ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities (NASDAQ:ZIOP)
www.twst.com - August 9 at 8:45 PM
sg.finance.yahoo.com logoZiopharm reports 2Q loss (NASDAQ:ZIOP)
sg.finance.yahoo.com - August 9 at 8:45 PM

Social

Ziopharm Oncology (NASDAQ:ZIOP) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff